pharma · Prurigo Nodularis · Uremic Pruritus · TRVI
Trevi Therapeutics
Trevi Therapeutics trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.
195 Church Street, 16th Floor, New Haven, CT 06510, US HQ
2011 Founded
45 Employees
Public company Type
TRVI · NYSE Ticker
Company details
- Status
- Public
- HQ
- 195 Church Street, 16th Floor, New Haven, CT 06510, US
- Founded
- 2011
- Employees
- 45
- Programs
- 11
- Drugs
- 8
- Patents
- 7
Trevi Therapeutics clinical trials
Registry index of 15 ClinicalTrials.gov studies linked to Trevi Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Trevi Therapeutics trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Trevi Therapeutics.
-
NAL03-202 — Phase 2
Clinical update -
Nalbuphine HCl solution — Phase 1
Clinical update -
nalbuphine HCl ER tablets 90 mg BID — Phase 3
Clinical update -
nalbuphine HCl ER tablets 60 mg BID — Phase 3
Clinical update -
Nalbuphine ER Tablets — Phase 3
Clinical update -
Nalbuphine ER — Phase 1
Clinical update -
NAL ER — Phase 2
Clinical update -
NAL ER — Phase 2
Clinical update